Laboratory Corporation of America Holdings Looks to Continue to Trade Above its Annual-High Share Price Today

March 24, 2021 12:06:46

Laboratory Corporation of America Holdings (NYSE:LH) traded at a new 52-week high today of $254.91. Approximately 805,000 shares have changed hands today, as compared to an average 30-day volume of 796,000 shares.

In the past 52 weeks, Laboratory Corporation of America Holdings share prices are bracketed by a low of $100.33 and a high of $254.91 and is now at $251.07, 150% above that low price.

Laboratory Corporation of America Holdings (NYSE:LH) defies analysts with a current price ($251.07) 3.5% above its average consensus price target of $242.35.

Laboratory Corporation of America is one of the nation’s two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer